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Abstract
Background: Cytochrome P450 (CYP) enzymes in epithelial cells lining the alimentary tract play
an important role in both the elimination and activation of (pro-)carcinogens. To estimate the role
of cytochrome P450 in carcinogenesis of the colon, expression patterns and protein levels of four
representative CYPs (CYP2C, CYP2E1, CYP3A4 and CYP3A5) were determined in colon mucosa
of normal and adenomatous colonic tissue of patients with adenomas and disease-free controls.
Methods: Expression of CYP2C, CYP2E1, CYP3A4, and CYP3A5 in colon mucosa of normal and
adenomatous colonic tissue of patients with adenoma and disease-free controls was determined by
RT-PCR. Protein concentration of CYPs was determined using Western blot.
Results: With the exception of CYP3A5, expression of CYP mRNA was similar among groups and
tissues (e.g. normal colon mucosa and adenoma). CYP3A5 mRNA expression was significantly
higher in adenoma in comparison to normal tissue of patients with adenoma (~48%). When
comparing protein concentrations of CYPs measured in adenomas with neighboring normal colonic
mucosa no differences were found. However, in normal tissue of patients with adenomas, protein
levels of CYP2C8, CYP3A4 and CYP3A5, but not that of CYP2E1, were significantly lower than in
biopsies obtained from disease-free controls. Specifically, in normal colonic mucosa of patients
protein concentrations of CYP2C8, CYP3A4, and CYP3A5 were ~86%, ~69%, and ~54%,
respectively, lower than in disease-free controls.
Conclusion: In conclusion, among other factors, the altered protein levels of certain CYPs (e.g.
CYP2C8, CYP3A4 and CYP3A5) in colon mucosa might contribute to the development of
neoplasia in the colon.
Background
Cytochrome P450 enzymes (CYPs) play a key role in the
oxidative, peroxidative and reductive metabolism of
endogenous and exogenous compounds such as drugs,
dietary components and alcohols (for review see [1].).
However, CYPs not only function in the detoxification of
xenobiotics but may also be involved in the activation of
potential (pro-) carcinogens. Furthermore, it has been
suggested that the local expression of CYPs in tumors is
very important for the management of cancer since CYPs
expressed in tumors may be involved in activation and/or
inactivation of chemotherapeutic drugs (for review see
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xenobiotics, including potential (pro-) carcinogens.
Indeed, it has been proposed that extrahepatic tissue
might play an important role in the CYP-mediated metab-
olism of xenobiotic compounds and therefore eventually
the susceptibility of certain organs to the development of
neoplasia (e.g. colon); however, knowledge on regulation
and localization of CYP-mediated xenobiotic metabolism
outside the liver is limited.
CYP is most abundant in liver; however, the main CYP
families participating in the metabolism of xenobiotics
(e.g. CYP1, 2, 3) are also expressed in extrahepatic tissues
(for review see [3].). Kaminsky and Fasco [4]. have pro-
posed that members of cytochrome P450 families 3 (e.g.
CYP3A) and 2 (e.g. CYP2C), which are present in the
small intestinal epithelium at high concentrations [5],
protect the small intestine from carcinogenesis. Further-
more, it has been suggested that the absence of some of
these microsomal enzymes in the colon may be involved
in the comparably high incidence of carcinoma in this
organ [6]. However, the availability of data on human
colonic cytochrome P450 protein expression in unaf-
fected as well as in adenomatous tissue of the colon is lim-
ited. Furthermore, some of the published findings are
contradictory. For example, expression of mRNA for
CYP3A4 and CYP3A5 has been found in human colorec-
tal epithelium [7]. and in intestinal cell lines [8,9].
CYP2E1 protein has been detected in colon carcinoma cell
lines and in the colon [10,11]. but not in human peritu-
moral or tumoral tissue [12]. Expression of CYP2C7, cor-
responding to human CYP2C8, and CYP2C (including
CYP2C8-CYP2C19) in human and rat colon tissues has
been reported [11,13,14].
CYPs might play a critical role not only in the develop-
ment but also in treatment of colonic neoplasia. However,
knowledge on CYPs in colon is limited. Therefore, the aim
of the present study was to determine expression and pro-
tein concentrations of four representative CYPs (e.g.
CYP2C, CYP2E1, CYP3A4, and CYP3A5) in macroscopi-
cally normal colonic tissue of subjects with and without
colonic adenomas. As the expression of different xenobi-
otic-metabolizing enzymes may be altered throughout the
development of neoplasia, which is generally accepted to
follow the adenoma-carcinoma sequence, expression of
these cytochrome P450 genes was also measured in
colonic adenoma and compared to that of unaffected
neighboring colonic tissue of the same subjects.
Methods
Subjects
The study protocol was approved by the Ethics Committee
of the medical association Stuttgart, Germany, and fol-
lowed the ethical guidelines of the 1975 Declaration of
Helsinki. Informed consent was obtained from all sub-
jects. Colonic adenoma and surrounding normal colon
mucosa biopsies (each 5–10 mg) were obtained during
routinely performed coloscopies from 25 patients, aged
50 – 70 years (Table 1). In addition, biopsy specimens of
Table 1: Origin of tissue specimen and histology of colonic adenomatous tissue samples.
Patients with adenoma Disease-free controls
Normal tissue Adenoma Normal tissue
Ascending colon 8 7 8
Descending colon 8 12 5
Sigmoid colon and rectum 9 6 14
Tubular adenoma - 12 -
Tubular villious adenoma - 10 -
Villious adenoma - 3 -
Table 2: Clinical data of patients with adenoma and disease-free controls
Patients with adenoma Disease-free controls
Number (female/male) 25 (9/16) 27 (12/15)
Age 61 ± 5 59 ± 6
Body-mass index (BMI) 26.9 ± 4.8 26.4 ± 4.4
Cigarette usage: yes/no (number/d) 8/17 (2.9 ± 6.9) 5/22 (2.1 ± 6.5)
Alcohol consumers (more than 10 g/d): yes/no 8/17 4/23
Average alcohol intake (g/d) of consumers 15.1 ± 16.5 10.5 ± 13.5
Medication (yes/none) 15/10 17/10
All data are expressed as means ± SD.Page 2 of 10
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controls during routine endoscopy (age 50 – 70 years) dis-
playing no signs of colonic neoplasia or other diseases of
the colon. Immediately after removal of biopsies, colon
mucosa specimens were frozen in liquid nitrogen and
stored at -80°C. All patients completed a questionnaire
concerning factors that may influence the expression of
cytochrome P450 such as medication, smoking, and alco-
hol consumption (Table 2). Neither anthropometrics nor
medication differed significantly between the patient
group and that of disease-free controls. Patients and dis-
ease-free controls did not consume drugs known to inter-
fere with/ or to induce cytochrome P450 enzymes
investigated in this study.
Tissues and isolation of total RNA and protein
All colon mucosa specimens were immediately frozen in
liquid nitrogen after excision and stored at -80°C. Both
total RNA and protein were isolated using Trizol reagent
(Invitrogene, Gaithersburg, MD, USA).
Immunoblot analysis
Antibodies used for the detection of CYP2E1 and CYP3A4
were a generous gift of Dr. M. Ingelman-Sundberg, Karo-
linska Institute, Stockholm, Sweden. Primary antibodies
for the measurements of CYP2C8 and CYP3A5 were pur-
chased from Chemicon, Inc. (Frankfurt, Germany).
Microsomes and Supersomes were from cell lines/clones
over-expressing human CYP2C8, CYP2E1, CYP3A4, and
CYP3A5, respectively. They were used as internal stand-
ards for quantification and to test for cross reactivity of
antibodies (Gentest Corporation, Woburn, MA, USA).
Protein concentration was determined by the method of
Bradford [15], using a commercial preparation (BioRad,
Munich, Germany).
Twenty to 30 µg of total protein were separated by SDS-
polyacrylamid gel electrophoresis and transferred to
nitrocellulose membranes. To enable quantification of
CYP protein, a serial dilution of the appropriate standard
was proceeded identically. To ensure equal loading of
samples, membranes were pre-stained with Ponceau red
before blocking and incubation with antibodies. Mem-
branes were blocked in 5% non-fat milk in Tris-buffered
saline-Tween 20 (TBST, 0.01% v/v Tween 20) and probed
with dilutions of primary antibodies in TBS, followed by
an incubation with the secondary antibody. The protein/
antibody complex was visualized by enhanced chemilu-
minescence (SuperSignal® West Dura, Pierce, KTM, Bad
Godesberg, Germany). Blots were evaluated (Camera LAS
1000, Fuji, USA) and densitometric analysis was per-
formed using the software AIDA (Raytest, Isotopenmess-
geraete, Straubenhardt, Germany). Signal intensities of
the samples were adjusted to the intensities of the serially
diluted standards. To ensure equal loading some blots
were probed for β-actin (Sigma, St Louis, USA).
Reverse transcription and PCR
The integrity and concentration of RNA was analyzed in a
1.2% agarose gel. First-strand complementary DNA was
synthesized from 200 ng of total RNA using a First-Strand
cDNA Synthesis Kit (Invitrogen, Gaithersburg, MD, USA).
Sequences of primers are summarized Table 3. The PCR
reaction consisted of 0.6 µl of cDNA, 10 x PCR buffer, 200
µM dNTPs (Boehringer, Mannheim, Germany), BSA (0.25
mg/ml), DMSO (2% v/v), 0.5 µM of specific primer and
0.5 U Taq-polymerase (Promega, Madison, WI, USA), and
water to a final volume of 10 µl. For amplifications of the
four cytochrome P450 cDNAs, PCR-conditions were as
follows: 3 s at 94°C, 3 s at 45°C, 30 s at 72°C, for 32
cycles. Amplification of histone 3.3 was performed apply-
ing the following conditions: 3 s at 94°C, 3 s at 45°C, and
30 s at 72°C for 30 cycles. All PCR amplifications were
carried out in triplicate in a Rapid Cycler (Idaho Tec.,
USA) within the linear range of the reaction. PCR prod-
ucts were separated in a 1.5% agarose gel, stained with
ethidium bromide and photographed using a digital cam-
era from Biometra (Goettingen, Germany). To ensure the
success of PCR, human liver cDNA was used as a positive
control.
Statistical analysis
Results are presented as means ± standard error of the
mean (SEM) unless otherwise indicated. Fisher's exact test
was used to compare lifestyle data. The Mann-Whitney U-
test was used for the comparison of relative mRNA con-
centration and protein levels measured in normal colon
mucosa obtained from patients with adenoma and dis-
ease-free controls. Wilcoxon's t-test was used for the com-
parison of relative mRNA expression and protein
Table 3: Primers used for RT-PCR analysis
Sense primer Antisense primer PCR product (bp) Reference
Histone 3.3 GCGTGCTAGCTGGATGTCTT CCACTGAACTTCTGATTCGC 150 [25].
CYP2C8-19 GCTAAAGTCCAGGAAGAGATTGA TCCTGCTGAGAAAGGCATGAAGT 332 [26].
CYP2E1 AGCACAACTCTGAGATATGG ATAGTCACTGTACTTGAACT 365 [26].
CYP3A4 CCAAGCTATGCTCTTCACCG TCAGGCTCCACTTACGGTGC 324 [27].
CYP3A5 TGTCCAGCAGAAACTGCAAA TTGAAGAAGTCCTTGCGTGTC 472 [27].Page 3 of 10
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CYP3A5, CYP2E1, CYP3A4, and CYP2C mRNA expression in colon mucosa of patients with adenoma and disease-free con-trolsFigure 1
CYP3A5, CYP2E1, CYP3A4, and CYP2C mRNA expression in colon mucosa of patients with adenoma and dis-
ease-free controls. (A) Representative agarose gel of mRNA integrity. Lane 1 and 12 = positive control, lane 2–11 = RNA 
extracted from colonic mucosa biopsies. (B) Representative photomicrograph of RT-PCR products of two subjects. All meas-
urements were carried out in triplicate. Lanes 1, 6, 11: Histone 3.3; Lanes 2, 7, 12: CYP3A5; Lanes 3, 8, 13: CYP2E1; Lanes 4, 
9, 14: CYP3A4; Lanes 5, 10, 15 = CYP2C, bp = base pairs. (C) Quantitative analysis of CYP2C, CYP2E1, CYP3A4, and CYP3A5 
mRNA expression in normal colon mucosa and in colonic adenoma of patients. Results are normalized to histone 3.3 expres-
sion. Data are means ± SEM, ap < 0.05 compared to normal tissue. (D) Quantitative analysis of CYP2C, CYP2E1, CYP3A4, and 
CYP3A5 mRNA expression in normal colon mucosa of patients with colonic adenoma and disease-free controls. Results are 
normalized to histone 3.3 expression. Data are means ± SEM, ap < 0.05 compared to disease-free controls.
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Protein levels of CYP2C8, CYP2E1, CYP3A4, and CYP3A5 in macroscopically normal tissue and in adenoma of patients with colon c adenomaFigure 2
Protein levels of CYP2C8, CYP2E1, CYP3A4, and CYP3A5 in macroscopically normal tissue and in adenoma 
of patients with colonic adenoma. (A) Representative Western blots of CYP2C8, CYP2E1, CYP3A4, and CYP3A5 in mac-
roscopically normal colon mucosa (= N) and adenoma (= A) of patients with colonic adenomas and (B) quantitative analysis of 
blots are shown. CYP2E1, CYP3A4, and CYP3A5 protein levels were determined in 25 patients with adenoma. CYP2C8 pro-
tein levels were determined in 19 cases. Data are means ± SEM
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Diminished protein levels of CYP2C8, CYP3A4, and CYP3A5 in normal colon mucosa of patients with colonic adenomaFigure 3
Diminished protein levels of CYP2C8, CYP3A4, and CYP3A5 in normal colon mucosa of patients with colonic 
adenoma. (A) Representative Western blots of CYP2C8, CYP2E1, CYP3A4, and CYP3A5 in normal colon mucosa from 
patients with colonic adenomas and disease-free controls. (B) Representative Western blot of β-actin protein in normal 
mucosa of patients with colonic adenoma and disease-free controls. (C) Quantitative analysis of blots. CYP2E1, CYP3A4, and 
CYP3A5 protein levels were determined in 25 patients with adenoma und 27 disease-free controls. CYP2C8 protein levels 
were determined in 19 cases and 12 disease-free controls. Data are means ± SEM, ap < 0.05 compared to disease-free controls.
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Relation of CYP2C8, CYP3A4, CYP3A5 protein levels and mRNA expression pattern in normal colon mucosa of cases and dis-ease-free controlsFigure 4
Relation of CYP2C8, CYP3A4, CYP3A5 protein levels and mRNA expression pattern in normal colon mucosa 
of cases and disease-free controls. Comparison of protein levels of CYP2C8, CYP3A4, and CYP3A5 of patients and dis-
ease-free controls, respectively, with detectable mRNA expression and those with no detectable mRNA expression of the 
respective CYP. Data are mean ± SEM. ap < 0.05 compared to disease-free controls.
BMC Gastroenterology 2005, 5:34 http://www.biomedcentral.com/1471-230X/5/34concentration measured in normal colon mucosa and
colonic adenoma of the same subjects. Differences
accepted as significant had a significance level (P) of less
than 0.05.
Results
Expression of CYP2C, CYP2E1, CYP3A4, and CYP3A5 
mRNA in colon of patients with colonic adenoma and 
disease-free controls
High quality, non-degraded mRNA was obtained from
normal tissue of 20 disease-free controls and unaffected
tissue as well as adenomas of 18 patients with colonic ade-
noma. Expression of histone 3.3, which was used as
housekeeping gene, was detected in all samples. Figure 1
depicts representative agarose gels of RNA integrity and
results of RT-PCR measurements. Results of CYP2C,
CYP2E1, CYP3A4, and CYP3A5 mRNA expression are
summarized in Figures 1C and 1D. When comparing the
relative mRNA concentration of CYP2C, CP2E1, CYP3A4,
and CYP3A5 between adenomatous tissue and normal tis-
sue of patients with adenoma, significant differences were
only found for the expression of CYP3A5. Specifically,
CYP3A5 mRNA expression was significantly higher by
~48% in adenomatous tissue in comparison to normal
colonic tissue. No differences were found when compar-
ing CYP expression in normal tissue of patients with ade-
noma and disease-free controls.
Protein levels of CYP2C8, CYP2E1, CYP3A4, and CP3A5 in 
colon of patients with colonic adenoma and disease-free 
controls
Western blot analyses of CYP2E1, CYP3A4, and CYP3A5
were performed with specimens obtained from 25
patients with colonic adenoma and 27 disease-free con-
trols. Since higher protein concentrations were needed for
the detection of CYP2C8, protein concentration of
CYP2C8 was only determined in biopsies obtained form
19 cases and 12 disease-free controls. No differences were
found when comparing mean protein levels of CYP2C8,
CYP2E1, CYP3A4, and CYP3A5 measured in normal and
neoplastic tissue of patients with adenoma. Representa-
tive Western blots and quantitative analysis of blots are
depicted in Figure 2.
In addition, protein levels of CYPs were also determined
in colon mucosa biopsies of disease-free controls and
compared with those determined in macroscopically nor-
mal tissue of patients with colonic adenoma. Figure 3
depicts representative Western blots and quantitative
analysis of protein.
Protein levels of CYP2E1 in mucosal biopsies obtained
from normal colon mucosa of patients with adenoma did
not differ significantly from those measured in disease-
free controls. In contrast, mean protein level of CYP2C8
was significantly lower in unaffected, macroscopically
normal colon mucosa obtained from patients with ade-
noma than in samples obtained from disease-free con-
trols. Specifically, protein concentration of CYP2C8 in
colon mucosa obtained from patients with adenoma was
~85% lower than in tissue obtained from disease-free con-
trols. Similar results were found when comparing protein
levels of CYP3A4 and CYP3A5 between patients with ade-
noma and disease-free controls. CYP3A4 protein concen-
tration was ~69% lower in colon mucosa of patients with
adenoma in comparison to disease-free controls. Protein
level of CYP3A5 was ~54% lower in biopsies obtained
from patients with adenoma when compared to disease-
free controls.
Relation of protein levels and mRNA expression pattern of 
CYPs in normal colonic mucosa of patients with adenoma 
and disease-free controls
To further investigate whether differences found in pro-
tein levels of CYPs between normal tissue of patients with
adenoma and disease-free controls are related to the
mRNA expression of CYPs, protein levels of CYP2C8,
CYP3A4, and CYP3A5 of subjects with detectable mRNA
expression were compared to those with undetectable
mRNA expression of the respective CYP. CYP2E1 was
excluded from this comparison, since CYP2E1 expression
was only detected in three disease-free controls and two
patients with adenoma. No comparison was performed
with adenomatous tissue since the sample sizes were too
small (n < 5) for most of the CYPs investigated. Results are
summarized in Figure 4.
Despite the fact that expression of CYP2C was detected in
~50 % of patients with adenoma and disease-free con-
trols, no differences were found when comparing protein
levels of patients with adenoma and disease-free controls
with detectable and undetectable mRNA expression. Sim-
ilar, protein levels of CYP3A4 in disease-free controls with
undetectable mRNA expression did not differ from those
with detectable mRNA expression of CYP3A4. In contrast,
CYP3A4 protein levels of patients with adenoma with
undetectable mRNA expression of CYP3A4 were signifi-
cantly higher when compared to those with detectable
mRNA expression. Specifically, protein levels were ~68 %
higher in patients with adenoma with undetectable
mRNA expression. In disease-free controls, protein con-
centration of CYP3A5 did not differ between disease-free
controls with detectable und undetectable CP3A5 mRNA
expression. Similar to CYP3A4, protein levels of CYP3A5
were ~46 % higher in patients with undetectable mRNA
expression in comparison to those with detectable mRNA
expression of CP3A5. However, due to a large inter-indi-
vidual variability differences were not statistically signifi-
cant (p = 0.098).Page 8 of 10
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Protein levels of CYPs are decreased in normal tissue of 
patients with colonic adenoma
Carcinogens and pro-carcinogens present in the diet are
critical environmental factors influencing the develop-
ment of carcinoma in the large intestine. Cytochrome
P450-mediated metabolism of (pro-)carcinogens has
been shown – depending upon the compound – to either
result in detoxification or toxification (for review see [1])
and might therefore have potential impact on the devel-
opment of neoplasia. Furthermore, most human CYPs
have been found to be genetically polymorphic and these
polymorphisms may affect the enzyme expression and
activity subsequently leading to an increased risk to
develop several forms of cancer but also effecting treat-
ment (for review see [16]). Only a few extensive studies on
the mRNA and protein expression of cytochrome P450 in
colonic tissue and colonic adenoma have been performed
thus far. The presence of CYP2C-, CYP2E- and CYP3A- in
normal and in neoplastic colonic mucosa along with sub-
stantial inter-individual variability has been reported by
others before [12,14,17,18]. However, some of the availa-
ble data are contradictory and most studies either deter-
mined mRNA expression or protein levels [14,18]. For
example, Yokose et al. [14] showed the presence of
CYP2C (CYP2C8-CYP2C19) protein in both unaffected
and neoplastic human colon mucosa using immunohis-
tochemical methods. In contrast, Western blot analyses of
de Waziers et al. [18] and Massaad et al. [12], who both
used conventional immunoperoxidase staining proce-
dures, showed neither cytochrome P450 2C8-10 nor 2E1
to be present in normal colon mucosa and in colon carci-
noma. McKay et al. [17], who used immunohistochemical
methods, detected CYP3A protein more frequently in neo-
plastic tissue in colon mucosa specimens of patients with
neoplasia than in the morphologically normal mucosa of
these patients. Expression of CYP3A4 and CYP3A5 has
been reported for human colon mucosa [19,20]. In the
present study, the expression and protein levels of four
representative CYPs were determined in macroscopically
normal colon mucosa and adenoma of patients with ade-
noma and disease-free controls. At the level of mRNA
expression, only the expression of CYP3A5 was found to
be significantly altered between neoplastic tissue and nor-
mal, unaffected mucosa of patients with adenoma. How-
ever, as reported by others before, mRNA expression of all
four CYPs varied extensively between individuals even
though the expression of the housekeeping gene histone
3.3 was detected in all samples and was used for normal-
ization. At the level of protein, CYP2C8, CYP3A4, and
CYP3A5 protein concentration was found to be signifi-
cantly lower in normal tissue of patients with adenoma
than in colon mucosa of disease-free controls. Even
though previous studies have indicated that the abun-
dance of CYP protein is altered between neoplasia and
normal tissue [17], in the present study protein levels of
CYPs were found to be similar in neoplasia and normal
tissue of patients with adenoma. Taken together, these
data suggest that CYP expression not only varies exten-
sively between individuals but that protein levels of some
CYPs (e.g. CP2C8, CYP3A4, and CYP3A5) are considera-
bly lower in normal tissue of patients with adenoma in
comparison to those of disease-free controls.
CYP protein levels and mRNA expression are not related in 
normal colonic tissue
It has been suggested that expression of CYPs is not solely
regulated at the level of gene transcription [11]. This is
supported by the results of animals studies, reporting a
dissociation of mRNA expression and protein levels of
CYP2C7 (corresponding to human CYP2C8) and CYP2E1
in rat colon mucosa as well as CYP3A4 and CYP3A5 in
duodenum and kidney. Furthermore, in vitro studies per-
formed in rat hepatocytes indicate that CYP2E1 is regu-
lated by posttranscriptional ligand-dependent
stabilization of the enzyme [21]. Similar mechanisms
have been described for CYP3A in rats and humans
[22,23]. Using cultured hepatocytes it also has been
showed that only ~60–70% of mRNA encoding for
CYP2E1 is translated [24]. Indeed, in the present study, no
relation with respect to protein levels of subjects with
detectable and undetectable mRNA expression of the
CYPs was found. Instead, protein levels of CYP2C8,
CYP3A4, and CYP3A5 did not differ in disease-free con-
trols. In contrast, in normal tissue of patients with adeno-
mas protein levels of CYP3A4 and CYP3A5 were contrary
to mRNA expression pattern. Taken together, these data
suggest that in colon mucosa the expression of CYP2C8,
CYP3A4, and CYP3A5 is not solely regulated at the level
of transcription and that the mechanism of regulation, at
least for some CYPs (e.g. CYP3A4 and CYP3A5), might
differ between patients with colonic adenoma and
healthy subjects.
Conclusion
In summary, inter-individual variability along with a sub-
stantial dissociation of mRNA expression pattern and pro-
tein levels seems to be a characteristic of CYP expression
in the colon as has been reported in part by others before
[12,14,17,18]. However, in the present study protein lev-
els of CYP2C8, CYP3A4, and CYP3A5 were found to be
significantly lower in normal unaffected colonic mucosa
of patients with colonic adenoma in comparison with dis-
ease-free controls. Although the metabolic implications of
these differences remain to be determined, reduced levels
of some CYPs might result in an altered metabolism of
xenobiotics and therefore contribute to the development
of neoplasia in the large intestine. Future studies will
address this possibility.Page 9 of 10
(page number not for citation purposes)
BMC Gastroenterology 2005, 5:34 http://www.biomedcentral.com/1471-230X/5/34Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright




The author(s) declare that they have no competing inter-
ests.
Authors' contributions
IB has made substantial contributions to acquisition of
data, the biochemical analysis, and the drafting of article.
CB has made substantial contribution to conception and
design as well as the interpretation of data. AP has been
involved in the design, the drafting of the article, and
revised it critically for intellectual content. All authors
have given final approval of the version to be published.
Acknowledgements
The antibodies against human CYP2E1 and CYP3A4 were kindly provided 
by Dr. M. Ingelman-Sundberg. This work was supported by a grant from the 
Deutsche Krebshilfe (70-1881-B01) to AP and CB. The authors thank Gavin 
E. Arteel for his valuable comments.
References
1. Sheweita SA: Drug-metabolizing enzymes: mechanisms and functions.
Curr Drug Metab 2000, 1:107-132.
2. Oyama T, Kagawa N, Kunugita N, Kitagawa K, Ogawa M, Yamaguchi
T, Suzuki R, Kinaga T, Yashima Y, Ozaki S, Isse T, Kim YD, Kim H,
Kawamoto T: Expression of cytochrome P450 in tumor tissues
and its association with cancer development.  Front Biosci 2004,
9:1967-1976.
3. Ding X, Kaminsky LS: Human extrahepatic cytochromes P450:
function in xenobiotic metabolism and tissue-selective
chemical toxicity in the respiratory and gastrointestinal
tracts.  Annu Rev Pharmacol Toxicol 2003, 43:149-173.
4. Kaminsky LS, Fasco MJ: Small intestinal cytochromes P450.  Crit
Rev Toxicol 1991, 21:407-422.
5. Zhang QY, Dunbar D, Ostrowska A, Zeisloft S, Yang J, Kaminsky LS:
Characterization of human small intestinal cytochromes P-
450.  Drug Metab Dispos 1999, 27:804-809.
6. Peters WH, Kock L, Nagengast FM, Kremers PG: Biotransforma-
tion enzymes in human intestine: critical low levels in the
colon?  Gut 1991, 32:408-412.
7. Kolars JC, Lown KS, Schmiedlin-Ren P, Ghosh M, Fang C, Wrighton
SA, Merion RM, Watkins PB: CYP3A gene expression in human
gut epithelium.  Pharmacogenetics 1994, 4:247-259.
8. Chun YJ, Lee S, Yang SA, Park S, Kim MY: Modulation of CYP3A4
expression by ceramide in human colon carcinoma HT-29
cells.  Biochem Biophys Res Commun 2002, 298:687-692.
9. Pfrunder A, Gutmann H, Beglinger C, Drewe J: Gene expression of
CYP3A4, ABC-transporters (MDR1 and MRP1-MRP5) and
hPXR in three different human colon carcinoma cell lines.  J
Pharm Pharmacol 2003, 55:59-66.
10. White TB, Hammond DK, Vásquez H, Strobel HW: Expression of
two cytochromes P450 involved in carcinogen activation in a
human cell line.  Mol Cell Biochem 1991, 102:61-69.
11. Hakkak R, Korourian S, Ronis MJ, Ingelman-Sundberg M, Badger TM:
Effects of diet and ethanol on the expression and localization
of cytochromes P450 2E1 and P450 2C7 in the colon of male
rats.  Biochem Pharmacol 1996, 51:61-69.
12. Massaad L, de Waziers I, Ridbrag V, Janot F, Beaune PH, Morizet J,
Gouyette A, Chabot GG: Comparison of Mouse and Human
Colon Tumors with Regard to Phase I and Phase II Drug-
metabolizing Enzyme Systems.  Cancer Research 1992,
52:6567-6575.
13. Massaad L, Chabot GG, Toussaint C, Koscielny S, Morizet J, Bissery
MC, Gouyette A: Influence of tumor size on the main drug-
metabolizing enzyme systems in mouse colon adenocarci-
noma Co38.  Cancer Chemother Pharmacol 1994, 34:497-502.
14. Yokose T, Doy M, Taniguchi T, Shimada T, Kakiki M, Horie T, Matsu-
zaki Y, Mukai K: Immunohistochemical study of cytochrome
P450 2C and 3A in human non-neoplastic and neoplastic tis-
sues.  Virchows Arch 1999, 434:401-411.
15. Bradford MM: A rapid and sensitive method for the quantita-
tion of microgram quantities of protein utilizing the princi-
ple of protein-dye binding.  Anal Biochem 1976, 72:248-254.
16. Agundez JA: Cytochrome P450 gene polymorphism and can-
cer.  Curr Drug Metab 2004, 5:211-224.
17. McKay JA, Murray GI, Weaver RJ, Ewen SW, Melvin WT, Burke MD:
Xenobiotic metabolising enzyme expression in colonic neo-
plasia.  Gut 1993, 34:1234-1239.
18. De Waziers I, Cugnenc PH, Berger A, Leroux JP, Beaune PH: Drug-
metabolizing enzyme expression in human normal, peritu-
moral and tumoral colorectal tissue samples.  Carcinogenesis
1991, 12:905-909.
19. McKinnon RA, Burgess WM, Gonzalez FJ, McManus ME: Metabolic
differences in colon mucosal cells.  Mutat Res 1993, 290:27-33.
20. Mercurio MG, Shiff SJ, Galbraith RA, Sassa S: Expression of cyto-
chrome P450 mRNAs in the colon and the rectum in normal
human subjects.  Biochem Biophys Res Commun 1995, 210:350-355.
21. Eliasson E, Mkrtchian S, Ingelman-Sundberg M: Hormone- and sub-
strate-regulated intracellular degradation of cytochrome
P450 (2E1) involving MgATP-activated rapid proteolysis in
the endoplasmic reticulum membranes.  J Biol Chem 1992,
267:15765-15769.
22. Feierman DE, Melnikov Z, Zhang J: The paradoxical effect of
acetaminophen on CYP3A4 activity and content in trans-
fected HepG2 cells.  Arch Biochem Biophys 2002, 398:109-117.
23. Zangar RC, Hernandez M, Novak RF: Posttranscriptional eleva-
tion of cytochrome P450 3A expression.  Biochem Biophys Res
Commun 1997, 231:203-205.
24. Kocarek TA, Zangar RC, Novak RF: Post-transcriptional regula-
tion of rat CYP2E1 expression: role of CYP2E1 mRNA
untranslated regions in control of translational efficiency and
message stability.  Arch Biochem Biophys 2000, 376:180-190.
25. Futscher BW, Blake LL, Gerlach JH, Grogan TM, Dalton WS: Quan-
titative polymerase chain reaction analysis of mdr1 mRNA
in multiple myeloma cell lines and clinical specimens.  Anal
Biochem 1993, 213:414-421.
26. Hakkola J, Pasanen M, Purkunen R, Saarikoski S, Pelkonen O, Maenpaa
J, Rane A, Raunio H: Expression of xenobiotic-metabolizing
cytochrome P450 forms in human adult and fetal liver.  Bio-
chem Pharmacol 1994, 48:59-64.
27. Kivisto KT, Griese EU, Fritz P, Linder A, Hakkola J, Raunio H, Beaune
P, Kroemer HK: Expression of cytochrome P 450 3A enzymes
in human lung: a combined RT- PCR and immunohistochem-
ical analysis of normal tissue and lung tumours.  Naunyn
Schmiedebergs Arch Pharmacol 1996, 353:207-212.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-230X/5/34/pre
pubPage 10 of 10
(page number not for citation purposes)
